TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.9753
+0.0433 (4.65%)
At close: Feb 17, 2026, 4:00 PM EST
0.9860
+0.0107 (1.10%)
After-hours: Feb 17, 2026, 7:19 PM EST
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $55.35 million as of February 17, 2026. Its market cap has decreased by -62.04% in one year.
Market Cap
55.35M
Enterprise Value
-34.57M
1-Year Change
-62.04%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $55.35M, a decrease of -84.59%. That is a compound annual growth rate of -33.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 52.89M | -6.80% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grace Therapeutics | 55.86M |
| Radiopharm Theranostics | 55.10M |
| Metagenomi Therapeutics | 54.82M |
| Kazia Therapeutics | 54.59M |
| Instil Bio | 54.19M |
| NRx Pharmaceuticals | 53.29M |
| Estrella Immunopharma | 53.17M |
| NeurAxis | 52.31M |